Table 1 Comparisons in the patient and ocular characteristics in acute CRAO eyes between those not demonstrating and those demonstrating the mid-phase pinpoint hyperfluorescent spots on FFA at presentation
CRAO eyes without MPHS (n = 12) | CRAO eyes with MPHS (n = 11) | P value | |
|---|---|---|---|
Age (Median, IQR) [years] | 52.5 (48–70.5) | 41 (33–55) | 0.062 |
Gender (Males) (n, %) | 9 (75) | 8 (73) | > 0.999 |
Visual acuity range | LP negative – 6/60 | LP positive – 6/18 | |
Duration of symptoms (days) | 5.583 ± 1.775 | 2.182 ± 1.093 | 0.075 |
Presence of cilioretinal artery (n, %) | 6 (50) | 5 (45) | > 0.999 |
Mild CRAO (n, %) | 3 (25) | 1 (9) | 0.59 |
Moderate CRAO (n, %) | 4 (33) | 7 (64) | 0.22 |
Severe CRAO (n, %) | 5 (42) | 3 (27) | 0.67 |
ART (seconds) | 29.96 ± 11.06 | 21.76 ± 9.25 | 0.062 |